Oncology/Hematology
Hematology
More in Hematology
Ponatinib-blinatumomab led to durable remissions without transplant in most, but 13% relapsed
9 Hrs Ago
Experts at ASH debate quadruplet therapy, dexamethasone modulation, and novel approaches
Dec 20, 2024
Phase III trial sparks discussion on defining and managing high-risk smoldering myeloma
Dec 16, 2024
Higher response rate, PFS, OS with cilta-cel, but ide-cel had lower rate of severe toxicity
Dec 11, 2024
SAHARA rounds out this year's notable trials on blood transfusions in critically ill patients
Dec 10, 2024
Better disease outcomes, measures of cognition, and quality-of-life vs standard care, study finds
Dec 10, 2024
1.00
CME Credits